drugset

drugset / Trial / NCT02819310

An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults

NCT02819310 ↗

Phase 3 Completed 330 enrolled Braintree Laboratories

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety of chronic use of BLI400 laxative in constipated adults.

Timeline

Start: 2016-06
Primary completion: 2017-08
Completion: 2017-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lactitol	Small molecule	—	Oral

Indications